Trials / Completed
CompletedNCT02474953
A Study to Compare the Pharmacokinetic Profile of a Proprietary Curcumin Forumulation to a Comparator Curcumin Product
A Randomized, Double-blind, Crossover Study to Compare the Pharmacokinetic Profile of a Proprietary Curcumin Formulation to a Comparator Curcumin Product
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- KGK Science Inc. · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This study is investigating the pharmacokinetic profile (i.e. the way the product is processed by the body) of a proprietary curcumin formulation compared to an unformulated curcumin product. Subjects will take a single dose of either the proprietary formulation or comparator product and the blood levels of curcumin and curcumin metabolites will be measured over a period of 48 hours.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Proprietary Curcumin Formulation | |
| DIETARY_SUPPLEMENT | Unformulated Comparator Curcumin Product |
Timeline
- Start date
- 2015-04-01
- Primary completion
- 2015-06-01
- Completion
- 2015-06-01
- First posted
- 2015-06-18
- Last updated
- 2015-09-23
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT02474953. Inclusion in this directory is not an endorsement.